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SUPPLEMENT - EARLY GLIAL DYSFUNCTION
Rapid astrocyte and microglial activation following
pilocarpine-induced seizures in rats
Lee A. Shapiro, Lulu Wang, and Charles E. Ribak
Department of Anatomy & Neurobiology, School of Medicine, University of California at Irvine, Irvine,
California, U.S.A.
SUMMARY
Astrocyte and microglial activation occurs follow-
ing seizures and plays a role in epileptogenesis.
However, the precise temporal and spatial re-
sponse to seizures has not been fully examined.
The pilocarpine model of temporal lobe epilepsy
was selected to examine glial changes following
seizures becausemorphological changes in the hip-
pocampus closely mimic the human condition. As-
trocytic and microglial changes in the hippocam-
pus were examined during the first 5 days after
pilocarpine-induced seizures in rats by analyzing
GFAP, Iba1 and S100B-immunolabeling in CA1,
CA3, and the hilus. Also, 3-dimensional reconstruc-
tions of microglial cells from the hilus and granule
cell layer were analyzed. Lastly, astrocyte hyper-
trophy was examined in the hilus using electron
microscopy. At 1 day after seizures and contin-
uing throughout the 5 days examined, hypertro-
phied Iba1-labeled microglial cells and glial fibril-
lary acidic protein (GFAP)-labeled astrocytes were
observed. At 1 and 2 days after seizures, signifi-
cantly greater Iba1 immunolabeling was observed
in CA1, CA3, and the hilus. In addition, both the
area of Iba1 labeled processes and the number of
their endings were increased in the hilus beginning
at 1 day after seizures. S100B-immunolabeling was
significantly elevated in CA3 at 1 day, in CA3 and
CA1 at 2 days, and in all three hippocampal regions
at 3 days after seizures. Electron microscopy con-
firmed astrocytic hypertrophy and demonstrated
astrocytic cell bodies in the location where glial
endfeet normally appear on capillaries. The dif-
ferential response patterns of astrocytes and mi-
croglial cells following pilocarpine-induced seizures
may signify their detrimental role in neuroinflam-
mation after seizures.
KEY WORDS: Temporal lobe epilepsy, Dentate
gyrus, Hippocampus, Astrocyte hypertrophy, Glial
filaments.
Astrocyte and microglial activation are well-described
features of temporal lobe epilepsy (TLE), and studies have
suggested that glial cells may contribute to epileptogen-
esis (Briellmann et al., 2002; Vessal et al., 2005; Kang
et al., 2006; Binder & Steinha¨user, 2006). Other studies
have shown that after seizures, hypertrophied astrocytes in
the dentate gyrus form an ectopic glial scaffold that pro-
motes the aberrant growth of basal dendrites into the hilus
(Shapiro et al., 2005a; Shapiro & Ribak, 2006). These basal
dendrites are targeted for synaptogenesis by mossy fibers
(Ribak et al., 2000; Shapiro & Ribak, 2006) and contribute
to a recurrent excitatory circuit that may facilitate seizures
(Austin & Buckmaster, 2004). While astrocyte and mi-
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croglial activation might play a role in facilitating the sub-
sequent appearance of spontaneous seizures, the process
of glial activation is complex, and the precise temporal and
spatial sequelae of the neuroinflammatory response follow-
ing seizures are not well-studied (Borges et al., 2003).
The rodent-pilocarpine model of TLE is commonly
used to examine the neuroplastic changes that occur
in the epileptic brain, including mossy fiber sprout-
ing (Mello et al., 1993; Buckmaster et al., 2002), cell
death (Mello et al., 1993), increased neurogenesis (Parent
et al., 1997; McCloskey et al., 2006) and persistent
basal dendrites that receive mossy fiber synapses in
the hilus (Ribak et al., 2000; Shapiro & Ribak, 2006).
These changes were initially described at 30 days after
pilocarpine-induced seizures, a time point after the on-
set of spontaneous seizures. More recently, similar neuro-
plastic changes have been shown to occur within the first
5 days after pilocarpine-induced seizures (Shapiro et al.,
33
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2007a). Considering that neuroplastic changes occur im-
mediately following the seizures, and that astrocyte activa-
tion might contribute to the epileptogenic condition (Ni-
quet et al., 1994; Briellmann et al., 2002; Drage et al.,
2002; Garzillo & Mello, 2002; Vessal et al., 2005; Kang
et al., 2006; Binder & Steinha¨user, 2006), the current study
was designed to define the progression of astrocyte and mi-
croglial activation at 1–5 days after pilocarpine-induced
seizures. This was accomplished using an immunocyto-
chemical analysis of astrocytes and microglial cells labeled
with antibodies for glial fibrillary acidic protein (GFAP)
and Iba1, respectively.
In addition to these two glial cell types, S100B-labeled
astrocytes were also examined. S100B has been shown to
be involved in the neuroinflammatory response to many
neuropathological conditions (Griffin et al., 1989; Li et al.,
2000), including human TLE (Griffin et al., 1995). Anti-
bodies to the S100B protein can be used to assess vary-
ing degrees of neuroinflammation (Rothermundt et al.,
2003). There are reports showing that S100B is involved
with intermediate glial filament assembly and disassem-
bly, as well as polymerization of GFAP (Selinfreund et al.,
1991; Bianchi et al., 1996; Ueda et al., 1994). Moreover,
S100B stimulates microglial cell activation (Yan et al.,
1996; Sheng et al., 1997) and S100B expression is in-
creased 30 days after kainate-induced lesions (Bendotti
et al., 2000). Therefore, the distribution of S100B-labeled
cells was mapped throughout the hippocampus at 1–5 days
after pilocarpine-induced seizures.
Comparisons between the control group and each of the
time points following pilocarpine administration were per-
formed on the levels of immunoreaction product for each
antibody. Moreover, the morphology of Iba1-labeled mi-
croglial cells was characterized by tracing 3-D reconstruc-
tions, and an analysis was performed to compare process
thickness and branching patterns in response to seizure ac-
tivity. Lastly, electron microscopy was used to examine as-
trocytic hypertrophy following seizures.
METHODS
Animals
Adult male Sprague-Dawley rats (N = 24) were used
for this study. All protocols and experiments were car-
ried out in accordance with the Institutional Animal Care
and Use Committee at the University of California, Irvine.
Pilocarpine (320–340 mg/kg, i.p.) was used to induce
seizures as previously described (Shapiro et al., 2007a).
At the appropriate time points after seizures, the rats were
deeply anesthetized with euthasol and transcardial perfu-
sions were carried out using 250 ml of 0.9% sterile saline,
followed by 4.0% paraformaldehyde. The brains were al-
lowed to postfix in the skull for 24 h, after which they
were dissected out and placed in 4.0% paraformaldehyde
for 24 h. The brains were then transferred to phosphate-
buffered saline (PBS) and 50 μm sections were cut using a
vibratome.
Immunohistochemistry
Sections used for immunocytochemistry were 50 μm in
thickness and were incubated in 0.5% H2O2 for 30 min,
followed by 60 min in 1% H2O2, and then again for
30 min in 0.5% H2O2. Sections were then rinsed with PBS
and incubated free-floating in anti-GFAP (1:1000, Sigma,
St Louis, MO, U.S.A.), Iba1 (1:1000, Wako, Osaka, Japan),
or S100B (1:1000, Sigma), with 3% normal goat serum,
0.05% Triton-X in PBS, for 24 h rotating at room tem-
perature (RT). The tissue was then rinsed 3 times for
5 min in PBS and incubated for 1 h in biotinylated anti-
rabbit (GFAP and Iba1; 1:200, Vector Labs, Burlingame,
CA, U.S.A.), or anti-mouse (S100B; 1:200, Vector Labs
Burlingame, CA, U.S.A.) IgG, rotating at RT. For flu-
orescent staining, the tissue was incubated for 1.5 h in
fluorescent-tagged anti-rabbit (GFAP and Iba1; 1:200,
Molecular Probes, Carlsbad, CA, U.S.A.) or anti-mouse
(S100B; 1:200, Molecular Probes) IgG, rotating at RT. For
diaminobenzidine (DAB) stained sections, the tissue was
then rinsed in PBS 3 times for 5 min each rinse, and incu-
bated for 1 h in ABC (Vector Labs) solution, rotating at RT.
Following incubation, sections were rinsed with PBS for
20 min and were developed by incubating in 0.025% DAB
and 0.002% hydrogen peroxide, in PBS. The DAB re-
action was halted using PBS, followed by three 10 min
PBS rinses, after which the tissue was mounted onto glass
slides, dehydrated in graded alcohol baths, and coverslips
were applied using Permount (Sigma). For fluorescent re-
actions, the tissue was rinsed in PBS following the sec-
ondary reaction, mounted in distilled water, and coverslips
were applied using Fluoromount-G (Southern Biotech,
Birmingham, AL, U.S.A.).
Image analysis
Distribution of astrocytes and microglial cells following
pilocarpine-induced seizures
The distribution, size, and morphology of the three im-
munolabeled cell types were plotted onto schematic dia-
grams of the hippocampus by a rater blind to the condi-
tion of the rats. At each of the time points examined (N =
4/time point) and in the control (N = 4), a minimum of 12
sections containing the hippocampus was examined from
each group.
Analysis of astroglial and microglial activation within
regions of the hippocampus
The magnitude of astroglial and microglial immunoreac-
tivity was measured using a computer-assisted image anal-
ysis program (The University of Texas ImageTool program
V. 3.0). Sections containing GFAP, S100B, or Iba1 labeled
glial cells were examined under a Zeiss light microscope
(Zeiss Axioplan, Thornwood, NY, U.S.A.). Grayscale im-
ages (N = 24 per region examined, per time point) were
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Figure 1.
Example of the densitometric method used to analyze immunolabeling in the hippocampus. In A, a light micrograph
containing GFAP immunolabeled cells (arrows) and processes from 1 day after seizures is shown. In B, the same
image is shown after digitally converting the image using the threshold feature of the ImageTool software (UTHSC).
Only those immunolabeled elements that fall into the threshold range are converted to pure black pixels and the
rest of the image is converted to pure white pixels. The software automates the analysis by quantifying the total
number and percent of black and white pixels, allowing for statistical analysis of the data. Scale bars = 10 μm for A
and B.
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digitally captured from stratum radiatum of CA1 and CA3,
as well as from the hilus of the dentate gyrus. A 300
μm2 box was then randomly placed within the region
of interest, and this area was used for analysis. The im-
ages were analyzed using the ImageTool (University of
Texas Health Science Center) software which automates
the analysis by converting all immunolabeled elements that
fall within a threshold range into pure black pixels, and
the rest of the image is converted into pure white pixels
(see Fig. 1). The software then calculates the percentage
of pure black and white pixels, allowing for the compari-
son of the pixel values between the groups using a one-way
ANOVA. Planned-comparisons were carried out using the
Bonferroni test.
3-D reconstructions of Iba1 labeled microglial cells
To determine the process area and branching patterns of
the Iba1 expressing microglial cells, images were captured
from the hilus (N = 12 cells per time point and 3 from the
control) and dentate gyrus granule cell layer (GCL) (N =
8 cells per time point and 2 for the control). Confocal im-
age stacks were captured as previously described (Shapiro
et al., 2007b). The image stacks were then traced using the
Stereo Investigator software (MicroBrightfield Inc., Willis-
ton, VT, U.S.A.), and a branched structure analysis was
performed to examine the process length per cell, number
of endings per cell (an indicator of ramification) and to-
tal process area. Total process area was examined because
microglial hypertrophy typically involves a thickening, and
not necessarily a lengthening, of the microglial processes.
Statistical analysis of the data was performed using a one-
way ANOVA, and planned-comparisons were carried out
using the Bonferroni test.
Electron microscopy
Sections from the hippocampus were processed for
electron microscopy using a previously described method
(Shapiro & Ribak, 2006). Briefly, hippocampal sections
were postfixed in 1% glutaraldehyde for 1 h, then rinsed
in PBS and placed in 1% osmium tetroxide for 20–60 min,
and dehydrated by ethanol and propylene oxide immer-
sion. A flat-embedding procedure was used after which
the tissue block was trimmed using a single-edged razor
blade under a dissecting microscope. A short series of ul-
trathin (60–80 nm) sections containing the dentate gyrus
from each block was cut with an ultramicrotome (UltraCut
E, Reichert-Jung, Wetzlar, Germany), and sequential sec-
tions were collected on mesh and formvar-coated slot grids.
The sections were stained with uranyl acetate and lead cit-
rate to enhance contrast. Sections containing the GCL and
hilus were examined with a Philips CM-10 transmission
electron microscope, and images of astrocytic somata and
processes were captured with a Gatan digital camera.
RESULTS
Distribution of glial cells in the hippocampus following
pilocarpine-induced seizures
At 1 day after pilocarpine-induced seizures, hypertro-
phied GFAP-labeled astrocytes (Fig. 1) and Iba1-labeled
microglial cells (Fig. 2) were seen throughout the hip-
pocampal CA1 and CA3 regions, and in the dentate gyrus.
Many of the Iba1-labeled cells at this time point were
pleomorphic, with thickened processes and increased
branchpoints, indicative of activated microglial cells. In-
terestingly, the Iba1 cells at the border between the sub-
granular zone and the base of the GCL were the most
Epilepsia, 49(Suppl. 2):33–41, 2008
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Figure 2.
Confocal micrographs of Iba1 labeled microglial cells in the hilus of the dentate gyrus from control (A) and epileptic
rats (B–D). In A, an example of a labeled-cell is shown from the control. Note the typical resting microglial
appearance with its round cell body (arrow) and normal appearing processes with relatively few ramifications. In B,
a labeled microglial cell is shown at 1 day after pilocarpine-induced seizures. Note the activated appearance with
its elongated cell body (arrow), thickened processes and increased number of branches. In C, a labeled microglial
cell is shown at 3 days after seizures. Note that this cell still has an activated appearance. In D, a labeled microglial
cell is shown at 5 days after seizures. Note that this cell also retains an activated appearance: indicating microglial
activation for the duration of the examined time points. Scale bars = 10μm for A-D.
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intensely immunolabeled and displayed bushy/ramified
branching patterns. This population of Iba1-labeled mi-
croglial cells was not observed in the control rats. At the 1
day time point, there were relatively fewer GFAP-labeled
cells compared to the control rats. However, GFAP-labeled
astrocytes had a hypertrophied appearance with thickened
processes. In addition, S100B-labeled glial cells were
found that were surrounded by halos of S100B of vary-
ing intensity (not shown). This pattern of labeling for all
three antibodies was similar at the 2 day time point. No
compound granular corpuscles (aka Gitter cells) were ob-
served within the first 2 days after seizures, indicating that
necrosis was not yet complete. Beginning at 3 days and
continuing at the 4 and 5 day time points, most of the
Iba1 labeled microglial cells had an elliptical or elongated
cell body and thickened processes relative to the control
group. At the 3 day time point, the S100B cells appeared
more intensely-labeled throughout the regions examined,
and many of these cells had halos of S100B (not shown).
At 4 days after seizures, a majority of the GFAP- and Iba1-
labeled cells had a hypertrophied appearance. However, in
contrast to the 1–3 day time points, there was a greater pro-
portion of cells that lacked the hypertrophied appearance,
and instead appeared more like that of the control rats. At
5 days after seizures, some GFAP- and Iba1-labeled cells
still had an activated appearance, although greater than half
of these cells appeared relatively normal. It is pertinent to
note that several rod-like Iba1 labeled cells were found at
this time point, indicating chronic activation of these mi-
croglial cells (Fig. 3). The majority of the S100B-labeled
cells at the 5 day time point lacked the intense S100B la-
beling, and was similar in appearance to the control rats,
although diffuse halos of S100B were still observed around
some of these cells.
Morphometric analysis
Analysis of the 3-D reconstructions of Iba1 express-
ing microglial cells revealed several differences in the
Epilepsia, 49(Suppl. 2):33–41, 2008
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Figure 3.
3-D reconstructions of Iba1-labeled microglial cells in the hilus. The box enclosing the tracings depicts the x-, y-,
and z-axes. The cell bodies of all cells are in blue, the first-order processes are in yellow, second-order processes
are white, third order are magenta, fourth order are green, fifth order are light blue. The scale bars in each panel
are for the traced cells, whereas the confocal images in the lower right of each panel are merged composites and are
not to scale. In A, a typically appearing resting microglial cell is shown from the control group. In B, the microglial
cell from 1 day after seizures has an elongated cell body (blue) with thickened processes and increased branching.
In C (3 days), the cell body (blue) is more elongated and the processes are thick with complex ramifications. In D
(5 days), the cell body (blue) appears rod-like with many short thickened processes emanating from the cell body.
Scale bars = 10 μm.
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morphology of the microglial cells between the control
and experimental groups (Fig. 4). Although there were no
differences in the mean length of Iba1 labeled processes
between the controls and any of the rats that had experi-
enced seizures, significant differences were detected in the
mean area of these processes and number of their endings.
The results showed a significantly greater area of Iba1 la-
beled processes in the hilus at 1 day (p < 0.05), 2 days (p
< 0.05), 3 days (p < 0.005) and 5 days (p < 0.001) after
seizures as compared to the control group. No significant
differences were detected for the mean area of Iba1-labeled
processes in the GCL at any of the time points examined
(Fig. 4). Analysis of the mean number of endings of Iba1
labeled processes revealed a significantly greater number
of endings in the hilus at day 1 (p < 0.005) and day 5 (p
< 0.001) as compared to the control group. In the GCL, a
significantly greater number of endings was found at day 1
(p < 0.005) as compared to the control group.
Densitometric analysis
The quantitative data for the densitometric analysis are
shown in Fig. 5. At 1 day after seizures, there was increased
Iba1 immunoreactivity relative to the control group in all
three regions examined (hilus p < 0.05; CA1 p < 0.001;
CA3 p < 0.001). There was also an increase in S100B
immunoreactivity in CA3 (p < 0.05) at this time point.
At 2 days after seizures, there was increased Iba1 im-
munoreactivity relative to the control group in all three re-
gions examined (hilus p < 0.01; CA1 p < 0.05; CA3 p <
0.005). There was also an increase in S100B immunoreac-
tivity in CA1 (p < 0.05) and CA3 (p < 0.005) at this time
point. At 3 days after seizures, S100B immunoreactivity
Epilepsia, 49(Suppl. 2):33–41, 2008
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Figure 4.
Quantitative analysis of the mean length, number of
process endings and mean process area of Iba1 labeled
microglial cells in the hilus and granule cell layer (GCL).
In A, the mean length is shown. One way analysis of
variance did not reveal any significant differences at any
of the time points examined. In B, the graph depicting
the mean area of Iba1 labeled processes shows a sig-
nificantly greater area in the hilus as compared to the
control at 1 day (∗p < 0.05), 2 days (∗p < 0.05), 3 days
( p < 0.005) and 5 days (∗∗p < 0.001) after seizures. In
C, one way analysis of variance revealed significant dif-
ferences in the mean number of Iba1 labeled endings in
the hilus at 1 day (∗p < 0.005) and 5 days after seizures
(∗∗p < 0.001) .
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was increased relative to the controls in all of the regions
examined (p < 0.01 for all three regions). GFAP immuno-
labeling showed no significant differences at any of the five
time points following pilocarpine-induced seizures as com-
pared to the control.
Figure 5.
Graphs of the mean percentage of black pixels for the
Iba1, GFAP, and S100B immunocytochemical analysis.
In A, the mean percentage of black pixels representing
Iba1 labeling is shown. One way analysis of variance
revealed that there is significantly greater immunore-
activity at 1 day (∗hilus p < 0.05; CA1 and CA3 ∗∗p <
0.001) and 2 days (hilus p < 0.01; CA1 ∗p < 0.05; CA3
†p < 0.005) after seizures relative to the controls in
all of the regions examined. In B, the mean percentage
of black pixels representing GFAP immunolabeling is
shown. One way analysis of variance revealed no sig-
nificant differences were detected at any of the time
points examined. In C, the mean percentage of black
pixels representing S100B immunoreactivity is shown.
One way analysis of variance revealed that there is a
significant increase in CA3 (∗p < 0.05) at 1 day, CA1
(∗p < 0.05) and CA3 (†p < 0.005) at 2 days and in
all three regions examined at 3 days (∗p <0.05 for all
three regions.
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Electron microscopy of astrocyte hypertrophy
The control preparations of the hilus of the dentate gyrus
showed the typical features of astrocytes (Shapiro et al.,
2005b). The cell bodies of astrocytes were rarely found
adjacent to the basal lamina of capillaries. Instead, the
basal lamina was apposed by astrocytic endfeet, some of
which were thin attenuated processes separating neuropil,
while other processes were large and contained a watery
Epilepsia, 49(Suppl. 2):33–41, 2008
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Figure 6.
Electron micrographs of astrocytes in the hilus of the dentate gyrus from control (A, B) and epileptic rats (C–F).
A shows a low magnification of the subgranular zone with a capillary (asterisk) and a cell body of an astrocyte
(a). Note the elongated mitochondria (black arrowhead) and bundles of glial filaments (white arrowheads) in the
cytoplasm of the astrocyte cell body and proximal process. B is an enlargement of the capillary (asterisk) in A.
Note that small profiles of glial endfeet separate the myelinated axon (arrow) from the basement lamina of this
capillary. Another glial endfoot with vacuoles (black arrowheads) is shown on the lower right side of this capillary.
C and D show a capillary (asterisk) from a rat 1 day after pilocarpine-induced seizures. Note that the cell body of
an astrocyte (a) lies adjacent to the basal lamina (black arrowheads in D) of this capillary. Bundles of intermediate
filaments were observed in the cell body of this astrocyte. E and F show a reactive astrocyte (a) from a rat 5 days
after pilocarpine-induced seizures. Note the large bundle of intermediate filaments filling its perikaryal cytoplasm.
Scale bars for A and E = 2 um; for B–D and F = 1 μm.
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cytoplasm with heterogeneously sized vacuoles (Fig. 6).
The cell bodies of astrocytes within 10 μm of capillar-
ies had processes that contained bundles of intermediate
filaments and elongated mitochondria (Figs. 6A, 6B). In
the preparations obtained from rats 1 day after pilocarpine-
induced seizures, all of the capillaries examined in the hilus
had cell bodies of astrocytes apposed to the basal lamina
(Figs. 6C, 6D). These astrocytic cell bodies varied in the
number and size of the bundles of glial filaments, and their
contiguous astrocytic processes that apposed the basal lam-
ina of capillaries also contained bundles of glial filaments
(Figs. 6C, 6D). All these changes were also observed at
each of the later time points analyzed in this study. In addi-
tion, astrocyte cell bodies examined at later time points had
larger bundles of glial filaments (Figs. 6E, 6F), reflecting
the classically described glial hypertrophy as observed in
GFAP-labeled preparations of brain sections from epilep-
tic rats (Hansen et al., 1990).
DISCUSSION
The results from the current study show that the activa-
tion of astrocytes and microglial cells has a different spa-
tial and temporal response to pilocarpine-induced seizures.
These data will be discussed in the context of the cells’
distinctive morphological patterns and features.
The results suggest that within 1 day after seizures, an
early microglial response occurs in CA1, CA3, and the
dentate gyrus. The fact that Iba1 immunoreactivity remains
significantly elevated at 2 days after seizures coincides
with the fact that the microglial activation is ongoing at
this time point. It should be noted that the morphometric
analysis confirmed the early microglial activation observed
qualitatively, because the microglial cells were pleomor-
phic and at later time points appeared rod-like. The qual-
itative data also showed that the microglia remained in an
activated state at least 3–5 days after the initial convulsive
insult. The quantitative morphometric data supported this
conclusion, revealing significant increases in total process
area and an increased number of process endings indicative
of more branching.
The results showing that S100-B immunolabeling is ele-
vated beginning 1 day after the seizures in CA3 and contin-
uing through day 3 where it is elevated in all of the regions
examined reflects the role S100B plays in the neuroin-
flammatory response. Not only does S-100B stimulate the
expression and release of the proinflammatory cytokine
interleukin-6 (Li et al., 2000), but elevated S-100B is
associated with microglial cells expressing interleukin1α
(Sheng et al., 1997). Moreover, S100B inhibits intermedi-
ate filament assembly of GFAP (Ueda et al., 1994; Bianchi
et al., 1996), and experimental reduction of S-100B re-
sults in fewer GFAP positive glial cells (Selinfreund et al.,
1991). The increase in S100B shown here, beginning by 1
day and peaking at 3 days, may therefore be responsible for
stimulating the proliferation of astrocytes. This would be
consistent with a previous report showing a preferential in-
crease in the proliferation of GFAP-expressing radial glia-
like astrocytes at 3 days after kainate acid-induced seizures
(Huttmann et al., 2003).
While the densitometric analysis of GFAP did not show
any significant differences, the data might be misleading
because astereological analysis of the number of astro-
cytes was not performed. Previous studies have reported
that astrocytic cell death occurs following seizures (Borges
et al., 2006). It is possible that no net difference was seen
in the densitometric analysis because astrocyte hypertro-
phy of the surviving GFAP-labeled astrocytes compensated
for the death of GFAP-labeled cells following pilocarpine-
induced seizures. This glial hypertrophy was observed in
the light microscopic preparations and was also shown con-
vincingly in electron microscopic images obtained from
the hilus at all of the time points examined. The appear-
ance of hypertrophied processes with large bundles of glial
filaments as early as one day after seizures would presum-
ably be preceded by increased GFAP mRNA, which can be
seen in some regions of the hippocampus as early as 1.5 hrs
after pilocarpine-induced seizures (Belluardo et al., 1996).
In the normal adult subgranular zone, the basement
membrane of the capillaries is flanked by the traditional
astrocytic endfeet (Cajal, 1911; Peters et al., 1991; Shapiro
et al., 2005b). In the current study, by 1 day after seizures
and continuing throughout the 5 days examined, the cell
bodies of astrocytes appear adjacent to the capillaries, and
their swollen astrocytic cytoplasm contains large bundles
of intermediate filaments. In many cases, the cell body
of the astrocyte is so closely apposed to the basement
membrane (Fig. 6) that no classical astrocytic endfeet are
present. This is consistent with similar findings at 30 days
after pilocarpine-induced seizures (Shapiro et al., 2006).
Adult hippocampal neurogenesis has been shown to oc-
cur within an angiogenic niche, in close association with
the capillaries and the astrocytes (Palmer et al., 2000). Hip-
pocampal neurogenesis is altered at both short (Shapiro
et al., 2007a) and long (Parent et al., 1997) time points af-
ter pilocarpine-induced seizures, and this alteration may be
detrimental to the epileptic brain (Parent et al., 1997). It is
possible that seizure-induced alterations to the angiogenic
niche, such as a disruption of the blood-brain barrier (Bol-
wig et al., 1977; Petito et al., 1977) or altered astrocyte
buffering potential (Bordey & Sontheimer, 1998), might
underlie the seizure-induced alterations in hippocampal
neurogenesis. Kang et al., (2006) have shown that astrocyte
and microglial responses to pilocarpine-induced seizures in
the dentate gyrus precede neuronal damage and are related
to abnormal neurotransmission. Thus, controlling the rapid
astrocytic and microglial response to seizures might limit
the detrimental effects of seizure-induced neuroplasticity
and neurodegeneration, which could potentially enhance
the clinical efficacy of existing seizure therapy.
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